Business Development Development Genetic Disease Reagent 
Drug Discovery World
JANUARY 30, 2024
“Dr Naldini open new doors for cures for otherwise untreatable genetic diseases with the full impact of his work still untapped”, she said. High-cost materials: Specialised equipment, reagents, and cell culture media significantly contribute to the overall cost. Developing more efficient and affordable alternatives is key.
XTalks
OCTOBER 1, 2020
And although academia and industry have often been pitted against each other in the realm of scientific discovery and development, there may be more similarities and synergies between the two than we may think. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.
Expert insights. Personalized for you.
71 
Let's personalize your content